90 likes | 95 Views
The global antibacterial drugs market is majorly segmented by drug class type into beta-lactams, aminoglycosides, sulfonamides, tetracyclines, quinolones, phenicols, macrolides, and miscellaneous antibacterials. Beta-lactams occupies the largest share market of the global antibacterial drugs market followed by theu00a0quinolones. These drug classes will decline in the future during the forecast period, due to leading brands losing their market exclusivity, the surge in the number of drug-resistant bacterial strains and entry of generics in the market.
E N D
Global Antibacterial Drugs Market Antibacterial Drugs Market by Drugs Type, by Region, Market, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 Know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=513
Global Antibacterial Drugs Market Market Synopsis: The global antibacterial drugs market is expected to grow at the CAGR of 1.2% during 2020-2027. The global antibacterial drugs market is majorly segmented by drug class type into beta-lactams, aminoglycosides, sulfonamides, tetracyclines, quinolones, phenicols, macrolides, and miscellaneous antibacterials. Beta-lactams occupies the largest share market of the global antibacterial drugs market followed by the quinolones. These drug classes will decline in the future during the forecast period, due to leading brands losing their market exclusivity, the surge in the number of drug-resistant bacterial strains and entry of generics in the market.
Global Antibacterial Drugs Market Research Methoddolgy:
Global Antibacterial Drugs Market Global Antibacterial drugs Market Segmentation: By Drugs Type, 2018–2027 ($ Million) • Overview • Aminoglycosides • B-Lactams • Penicillins • Carbapenems • Cephalosporins • Tetracyclines • Sulfonamides • Quinolones • Macrolides • Phenicols • Miscellaneous Anti-bacterial Drugs • Pipeline Analysis
Global Antibacterial Drugs Market Global Antibacterial drugs Market Segmentation: • Projected sales of Phase III Drugs estimated till 2022 (US$ Mn) • Solithromycin • Actoxumab/bezlotoxumab (MK-3415A) • Cadazolid • Carbavance (meropenem/RPX7009) • Eravacycline • Omadacycline (PTK-0796) • Others • Tabular Representation of Phase II and I Drugs
Global Antibacterial Drugs Market Global Antibacterial drugs Market Segmentation: By Geography, 2018-2027 ($ Million) • North America (U.S. & Canada) • Europe (U.K., Germany & Rest of Europe) • Asia Pacific (China, Japan, and Rest of APAC) • Latin America (Brazil, Mexico and Rest of LATAM) • Middle East and Africa (UAE, Saudi Arabia, South Africa)
Global Antibacterial Drugs Market By Region:
Global Antibacterial Drugs Market List of Key Companies: • Pfizer Inc. • Novartis AG • Merck & Co. • Astra Zeneca plc • Johnson & Johnson Limited • Abbott Laboratories • Eli Lilly and Company • Sanofi SA • Bristol-Myers Squibb Company • Bayer AG • GlaxoSmithKline plc • Others
Global Antibacterial Drugs Market Media Contact: Company Name: Research CorridorContact Person: Mr. Vijendra SinghEmail: sales@researchcorridor.comContact no: +91 989-368-5690 Follow Us: